CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key Findings
3.2.1.Top Investment Pockets
3.3.Market dynamics
3.3.1.Drivers
3.3.1.1.Rise in incidence of chronic diseases and lifestyle associated disease
3.3.1.2.Increasing incidence of cancer and central nervous system (CNS) diseases
3.3.1.3.Surge in geriatric population across the globe
3.3.2.Restraint
3.3.2.1.Lack of awareness for clinical nutrition
3.3.2.2.Stringent regulations and poor reimbursement policies
3.3.3.Opportunities
3.3.3.1.Various growth opportunities in emerging economies
3.4.Impact of COVID-19 on Clinical Nutrition Market

CHAPTER 4:CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION
4.1.Overview
4.1.1.Market size and forecast
4.2.Oral
4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country
4.3.Enteral
4.3.1.Key trends and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.4.Parenteral
4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country

CHAPTER 5:CLINICAL NUTRITION MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Cancer
5.2.1.Market size and forecast
5.2.2.Market analysis, by country
5.3.Neurological Diseases
5.3.1.Market size and forecast
5.3.2.Market analysis, by country
5.4.Gastrointestinal Disorders
5.4.1.Market size and forecast
5.4.2.Market analysis, by country
5.5.Metabolic Disorders
5.5.1.Market size and forecast
5.5.2.Market analysis, by country
5.6.Others
5.6.1.Market size and forecast
5.6.2.Market analysis, by country

CHAPTER 6:CLINICAL NUTRITION MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Pediatric
6.2.1.Market size and forecast
6.2.2.Market analysis, by country
6.3.Adults
6.3.1.Market size and forecast
6.3.2.Market analysis, by country
6.4.Geriatric
6.4.1.Market size and forecast
6.4.2.Market analysis, by country

CHAPTER 7:CLINICAL NUTRITION MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key trends and opportunities
7.2.2.Market size and forecast, by country
7.2.3.Market size and forecast, by route of administration
7.2.4.Market size and forecast, by application
7.2.5.Market size and forecast, by end user
7.2.6.U.S.
7.2.6.1.U.S. market size and forecast, by route of administration
7.2.6.2.U.S. market size and forecast, by application
7.2.6.3.U.S. market size and forecast, by end user
7.2.7.Canada
7.2.7.1.Canada market size and forecast, by route of administration
7.2.7.2.Canada market size and forecast, by application
7.2.7.3.Canada market size and forecast, by end user
7.2.8.Mexico
7.2.8.1.Mexico market size and forecast, by route of administration
7.2.8.2.Mexico market size and forecast, by application
7.2.8.3.Mexico market size and forecast, by end user
7.3.Europe
7.3.1.Key trends and opportunities
7.3.2.Europe market size and forecast, by country
7.3.3.Europe market size and forecast, by route of administration
7.3.4.Europe market size and forecast, by application
7.3.5.Europe market size and forecast, by end user
7.3.6.Germany
7.3.6.1.Germany market size and forecast, by route of administration
7.3.6.2.Germany market size and forecast, by application
7.3.6.3.Germany market size and forecast, by end user
7.3.7.UK
7.3.7.1.UK market size and forecast, by route of administration
7.3.7.2.UK market size and forecast, by application
7.3.7.3.UK market size and forecast, by end user
7.3.8.Spain
7.3.8.1.Spain market size and forecast, by route of administration
7.3.8.2.Spain market size and forecast, by application
7.3.8.3.Spain market size and forecast, by end user
7.3.9.France
7.3.9.1.France market size and forecast, by route of administration
7.3.9.2.France market size and forecast, by application
7.3.9.3.France market size and forecast, by end user
7.3.10.Italy
7.3.10.1.Italy market size and forecast, by route of administration
7.3.10.2.Italy market size and forecast, by application
7.3.10.3.Italy market size and forecast, by end user
7.3.11.Rest of Europe
7.3.11.1.Rest of Europe market size and forecast, by route of administration
7.3.11.2.Rest of Europe market size and forecast, by application
7.3.11.3.Rest of Europe market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key trends and opportunities
7.4.2.Asia-Pacific market size and forecast, by country
7.4.3.Asia-Pacific market size and forecast, by route of administration
7.4.4.Asia-Pacific market size and forecast, by application
7.4.5.Asia-Pacific market size and forecast, by end user
7.4.6.Japan
7.4.6.1.Japan market size and forecast, by route of administration
7.4.6.2.Japan market size and forecast, by application
7.4.6.3.Japan market size and forecast, by end user
7.4.7.China
7.4.7.1.China market size and forecast, by route of administration
7.4.7.2.China market size and forecast, by application
7.4.7.3.China market size and forecast, by end user
7.4.8.India
7.4.8.1.India market size and forecast, by route of administration
7.4.8.2.India market size and forecast, by application
7.4.8.3.India market size and forecast, by end user
7.4.9.Australia
7.4.9.1.Australia market size and forecast, by route of administration
7.4.9.2.Australia market size and forecast, by application
7.4.9.3.Australia market size and forecast, by end user
7.4.10.South Korea
7.4.10.1.South Korea market size and forecast, by route of administration
7.4.10.2.South Korea market size and forecast, by application
7.4.10.3.South Korea market size and forecast, by end user
7.4.11.Rest of Asia-Pacific
7.4.11.1.Rest of Asia-Pacific market size and forecast, by route of administration
7.4.11.2.Rest of Asia-Pacific market size and forecast, by application
7.4.11.3.Rest of Asia-Pacific market size and forecast, by end user
7.5.LAMEA
7.5.1.Key market trends and opportunities
7.5.2.LAMEA market size and forecast, by country
7.5.3.LAMEA market size and forecast, by route of administration
7.5.4.LAMEA market size and forecast, by application
7.5.5.LAMEA market size and forecast, by end user
7.5.6.Brazil
7.5.6.1.Brazil market size and forecast, by route of administration
7.5.6.2.Brazil market size and forecast, by application
7.5.6.3.Brazil market size and forecast, by end user
7.5.7.South Africa
7.5.7.1.South Africa market size and forecast, by route of administration
7.5.7.2.South Africa market size and forecast, by application
7.5.7.3.South Africa market size and forecast, by end user
7.5.8.Saudi Arabia
7.5.8.1.Saudi Arabia market size and forecast, by route of administration
7.5.8.2.Saudi Arabia market size and forecast, by application
7.5.8.3.Saudi Arabia market size and forecast, by end user
7.5.9.Rest of LAMEA
7.5.9.1.Rest of LAMEA market size and forecast, by route of administration
7.5.9.2.Rest of LAMEA market size and forecast, by application
7.5.9.3.Rest of LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES
8.1.ABBOTT LABORATORIES
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.B. BRAUN MELSUNGEN AG
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product Portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments
8.3.BAXTER INTERNATIONAL INC.
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product Portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.DANONE NUTRICIA
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.5.FRESENIUS SE & CO. KGAA
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.6.HERO NUTRITIONALS INC.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.7.LONZA LTD.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.NESTLÉ S.A.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.9.PERRIGO COMPANY PLC
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.10.PFIZER INC.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance

List of Tables

TABLE 01.CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 02.ORAL CLINICAL NUTRITION MARKET, BY REGION, 2020-2028 ($MILLION)
TABLE 03.ENTERAL CLINICAL NUTRITION MARKET, BY REGION, 2020-2028 ($MILLION)
TABLE 04.PERENTERAL CLINICAL NUTRITION MARKET, BY REGION, 2020-2028 ($MILLION)
TABLE 05.CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 06.CANCER CLINICAL NUTRITION MARKET, BY REGION, 2020-2028 ($MILLION)
TABLE 07.NEUROLOGICAL DISEASES CLINICAL NUTRITION MARKET, BY REGION, 2020-2028 ($MILLION)
TABLE 08.GASTROINTESTINAL DISEASES CLINICAL NUTRITION MARKET, BY REGION, 2020-2028 ($MILLION)
TABLE 09.METABOLIC DISORDERS CLINICAL NUTRITION MARKET, BY REGION, 2020-2028 ($MILLION)
TABLE 10.OTHERS CLINICAL NUTRITION MARKET, BY REGION, 2020-2028 ($MILLION)
TABLE 11.CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 12.PEDIATRIC CLINICAL NUTRITION MARKET, BY REGION, 2020-2028 ($MILLION)
TABLE 13.ADULT CLINICAL NUTRITION MARKET, BY REGION, 2020-2028 ($MILLION)
TABLE 14.GERIATRIC CLINICAL NUTRITION MARKET, BY REGION, 2020-2028 ($MILLION)
TABLE 15.CLINICAL NUTRITION MARKET, BY REGION, 2020-2028 ($MILLION)
TABLE 16.NORTH AMERICA CLINICAL NUTRITION MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 17.NORTH AMERICA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 18.NORTH AMERICA CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 19.NORTH AMERICA CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 20.U.S. CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 21.U.S. CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 22.U.S. CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 23.CANADA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 24.CANADA CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 25.CANADA CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 26.MEXICO CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 27.MEXICO CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 28.MEXICO CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 29.EUROPE CLINICAL NUTRITION MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 30.EUROPE CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 31.EUROPE CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 32.EUROPE CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 33.GERMANY CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 34.GERMANY CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 35.GERMANY CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 36.UK CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 37.UK CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 38.UK CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 39.SPAIN CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 40.SPAIN CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 41.SPAIN CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 42.FRANCE CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 43.FRANCE CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 44.FRANCE CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 45.ITALY CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 46.ITALY CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 47.ITALY CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 48.REST OF EUROPE CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 49.REST OF EUROPE CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 50.REST OF EUROPE CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 51.ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 52.ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 53.ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 54.ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 55.JAPAN CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 56.JAPAN CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 57.JAPAN CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 58.CHINA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 59.CHINA CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 60.CHINA CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 61.INDIA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 62.INDIA CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 63.INDIA CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 64.AUSTRALIA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 65.AUSTRALIA CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 66.AUSTRALIA CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 67.SOUTH KOREA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 68.SOUTH KOREA CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 69.SOUTH KOREA CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 70.REST OF ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 71.REST OF ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 72.REST OF ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 73.LAMEA CLINICAL NUTRITION MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 74.LAMEA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 75.LAMEA CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 76.LAMEA CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 77.BRAZIL CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 78.BRAZIL CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 79.BRAZIL CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 80.SOUTH AFRICA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 81.SOUTH AFRICA CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 82.SOUTH AFRICA CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 83.SAUDI ARABIA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 84.SAUDI ARABIA CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 85.SAUDI ARABIA CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 86.REST OF LAMEA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 ($MILLION)
TABLE 87.REST OF LAMEA CLINICAL NUTRITION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 88.REST OF LAMEA CLINICAL NUTRITION MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 89.ABBOTT: COMPANY SNAPSHOT
TABLE 90.ABBOTT: OPERATING SEGMENTS
TABLE 91.ABBOTT: PRODUCT PORTFOLIO
TABLE 92.B. BRAUN: COMPANY SNAPSHOT
TABLE 93.B. BRAUN: OPERATING SEGMENTS
TABLE 94.B. BRAUN: PRODUCT PORTFOLIO
TABLE 95.BAXTER: COMPANY SNAPSHOT
TABLE 96.BAXTER: BUSINESS SEGMENT
TABLE 97.NUTRICIA: COMPANY SNAPSHOT
TABLE 98.NUTRICIA: OPERATING SEGMENTS
TABLE 99.NUTRICIA: PRODUCT PORTFOLIO
TABLE 100.FRESENIUS: COMPANY SNAPSHOT
TABLE 101.FRESENIUS: OPERATING SEGMENTS
TABLE 102.FRESENIUS: PRODUCT PORTFOLIO
TABLE 103.HERO: COMPANY SNAPSHOT
TABLE 104.HERO: OPERATING SEGMENTS
TABLE 105.HERO: PRODUCT PORTFOLIO
TABLE 106.LONZA: COMPANY SNAPSHOT
TABLE 107.LONZA: OPERATING SEGMENTS
TABLE 108.LONZA: PRODUCT PORTFOLIO
TABLE 109.NESTLÉ: COMPANY SNAPSHOT
TABLE 110.NESTLÉ: OPERATING SEGMENTS
TABLE 111.NESTLÉ: PRODUCT PORTFOLIO
TABLE 112.PERRIGO: COMPANY SNAPSHOT
TABLE 113.PERRIGO: OPERATING SEGMENTS
TABLE 114.PERRIGO: PRODUCT PORTFOLIO
TABLE 115.PFIZER: COMPANY SNAPSHOT
TABLE 116.PFIZER: OPERATING SEGMENTS
TABLE 117.PFIZER: PRODUCT PORTFOLIO

List of Figures

FIGURE 01.CLINICAL NUTRITION MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.CLINICAL NUTRITION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 04.COMPARATIVE SHARE ANALYSIS OF ORAL CLINICAL NUTRITION MARKET, BY COUNTRY, 2020 & 2028 (%)
FIGURE 05.COMPARATIVE SHARE ANALYSIS OF ENTERAL CLINICAL NUTRITION MARKET, BY COUNTRY, 2020 & 2028 (%)
FIGURE 06.COMPARATIVE SHARE ANALYSIS OF PERENTERAL CLINICAL NUTRITION MARKET, BY COUNTRY, 2020 & 2028 (%)
FIGURE 07.COMPARATIVE SHARE ANALYSIS OF CANCER CLINICAL NUTRITION MARKET, BY COUNTRY, 2020 & 2028 (%)
FIGURE 08.COMPARATIVE SHARE ANALYSIS OF NEUROLOGICAL DISEASES CLINICAL NUTRITION MARKET BY COUNTRY, 2020 & 2028 (%)
FIGURE 09.COMPARATIVE SHARE ANALYSIS OF GASTROINTESTINAL DISEASES CLINICAL NUTRITION MARKET BY COUNTRY, 2020 & 2028 (%)
FIGURE 10.COMPARATIVE SHARE ANALYSIS OF METABOLIC DISORDERS CLINICAL NUTRITION MARKET BY COUNTRY, 2020 & 2028 (%)
FIGURE 11.COMPARATIVE SHARE ANALYSIS OF OTHERS CLINICAL NUTRITION MARKET BY COUNTRY, 2020 & 2028 (%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF PEDIATRIC CLINICAL NUTRITION MARKET, BY COUNTRY, 2020 & 2028 (%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ADULT CLINICAL NUTRITION MARKET BY COUNTRY, 2020 & 2028 (%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF GERIATRIC CLINICAL NUTRITION MARKET BY COUNTRY, 2020 & 2028 (%)
FIGURE 15.ABBOTT: NET SALES, 2019-2020 ($MILLION)
FIGURE 16.ABBOTT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 17.ABBOTT: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 18.NET SALES, 2019-2020 ($MILLION)
FIGURE 19.B. BRAUN: NET SALES BY DIVISION, 2020 (%)
FIGURE 20.B. BRAUN: NET SALES BY REGION, 2020 (%)
FIGURE 21.NET SALES, 2019-2020 ($MILLION)
FIGURE 22.BAXTER: REVENUE SHARE BY BUSINESS UNIT, 2020 (%)
FIGURE 23.BAXTER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 24.FRESENIUS: NET SALES, 2019-2020 ($MILLION)
FIGURE 25.FRESENIUS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 26.FRESENIUS: REVENUE SHARE BY REGION, 2020(%)
FIGURE 27.NET SALES, 2019-2020 ($MILLION)
FIGURE 28.LONZA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 29.LONZA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 30.NET SALES, 2019-2020 ($MILLION)
FIGURE 31.NESTLÉ: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32.NESTLÉ: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 33.PERRIGO: NET SALES, 2019-2020 ($MILLION)
FIGURE 34.PERRIGO: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 35.PERRIGO: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 36.PFIZER NET SALES, 2019-2020 ($MILLION)
FIGURE 37.PFIZER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 38.PFIZER: REVENUE SHARE BY GEOGRAPHY, 2020 (%)

Companies Mentioned
Some of the key players operating in the global clinical nutrition market include Abbott Laboratories, B. Braun Melsungen AG, Danone Nutricia, Baxter International Inc., Fresenius SE & Co. KGaA, Perrigo Company Plc, Pfizer Inc., Lonza Ltd, Nestlé S.A., and Hero Nutritionals Inc.